Charles Schwab Investment Management Inc Enanta Pharmaceuticals Inc Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 161,000 shares of ENTA stock, worth $2.09 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
161,000
Previous 147,331
9.28%
Holding current value
$2.09 Million
Previous $1.39 Million
102.81%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding ENTA
# of Institutions
108Shares Held
21.7MCall Options Held
9.4KPut Options Held
3.3K-
Farallon Capital Management LLC San Francisco, CA2.1MShares$27.2 Million0.17% of portfolio
-
Morgan Stanley New York, NY2.05MShares$26.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.93MShares$25 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.84MShares$23.9 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY1.24MShares$16 Million0.29% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $269M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...